Pfizer and it’s German partner BioNTech sought approval in the US yesterday for an early rollout of its Covid-19 vaccine.
The US Food and Drug Administration (FDA) said its vaccines committee would meet on 10th December to discuss the request for emergency use authorization.
“The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines,” the organization’s head Stephen Hahn said in a statement.
“I want to assure the American people that the FDA’s process and evaluation of the data for a potential Covid-19 vaccine will be as open and transparent as possible.”
He said he could not predict how long the review would take, but the federal government said earlier the final green light would probably come in December.